跳至主要内容
临床试验/CTRI/2025/07/090273
CTRI/2025/07/090273尚未招募2 期

Three Arm Comparative Clinical Study To Evaluate The Efficacy of Triphaladi Churna Orally, Vidangadi Udvartana Topically and Both combined together in Vicharchika with special reference to Eczema

Dr Shreya Subhash Gunjal1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年7月20日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
1. To study the efficacy of Vidangadi Udvartana topically using EASI score.

研究概览

简要总结

Mahakushta and Kshudrakushta are the two categories into which kushta roga is divided. Kshudrakushta has a description of Vicharchika. Ayurvedic dermatologist frequently face the kind of Kshudrakushta known as Vicharchika. Clinically eczema and vicharchika have frequently been linked. Modern medicine has therefore made significant advancements, notably in the field of dermatology, but when some medications like steroids are overused or abused, they have catastrophic adverse effects like nephrotoxicity, osteoporosis, skin cancer etc while Ayurveda heals many cases of eczema without any negative side effects , by balancing the Dosha and Dhatus. According to Ayurveda, Vicharchika is Rakta Pradoshaja Vikara with 3 dosha involvement and a dominant Kapha Dosha. I have choose Triphaladi Churna and Triphala- Vidang Churna 17. because of properties of these drugs. Triphala acts as a Rasayana, Kledagna, Tridoshaghna ( specially kaphaghna ) . Vidang is mentioned in Charak as Krumighna and Kushtagna. Pimpali acts as Rasayana , Pachana dravya and Vaat-Kaphaghna dravya. These all properties helps in reducing symptoms namely kandu(Itching), Srava(discharge), aaraktata(Redness) , daha(Burning), Vaivarnya (discolouration) in vicharchika according to Yoga Ratnakar.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)

入选标准

  • Age group:.
  • 18 to 60 years. 2.Patients with clinical features of Vicharchika having signs and symptoms namely Kandu(itching),Pidaka(Eruption),Vaivarnya(Depigmentation) and Srava (Discharge).
  • Patients of both Gender.
  • Understanding and being willing to sign the informed consent form.

排除标准

  • Patient having severe systemic diseases or condition along with Vicharchika.
  • Pregnant & Lactating women.
  • Known case of Diabetes Mellitus.
  • Any other infective skin disorder.

结局指标

主要结局

1. To study the efficacy of Vidangadi Udvartana topically using EASI score.

时间窗: 12 Weeks

2. To study the efficacy of Triphaladi Churna orally using EASI score.

时间窗: 12 Weeks

3. To study the combined efficacy of Triphaladi Churna (orally) and Vidangadi Udvartana

时间窗: 12 Weeks

(topically) in using EASI score.

时间窗: 12 Weeks

次要结局

  • To compare the effect of Triphaladi Churna (orally) with Vidangadi Udvartana (topically) in signs(and symptoms of Vicharchika .)

研究者

发起方
Dr Shreya Subhash Gunjal
申办方类型
Other [Govt aided ayurvedic hospital]
责任方
Principal Investigator
主要研究者

Dr Shreya Subhash Gunjal

Arogyashala Rugnalaya Panchavati Nashik

研究点 (1)

Loading locations...

相似试验

Study to evaluate use of triphaladi churna orally... | 临床试验